4//SEC Filing
Kalnik Matthew W. 4
Accession 0001455244-11-000019
CIK 0000072444other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:18 PM ET
Size
8.8 KB
Accession
0001455244-11-000019
Insider Transaction Report
Form 4
Kalnik Matthew W.
SVP Strategic Plan. & Bus. Ops
Transactions
- Award
Common Stock
2011-04-01+30,000→ 71,050 total - Sale
Common Stock
2011-04-01$5.80/sh−6,300$36,530→ 41,050 total - Award
Stock Option (right to buy)
2011-04-01+75,000→ 75,000 totalExercise: $5.81Exp: 2018-04-01→ Common Stock (75,000 underlying)
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Restricted Stock which vests in four equal annual installments beginning on April 1, 2012.
- [F3]This Option will become exercisable in four equal annual installments beginning on April 1, 2012.
Documents
Issuer
NABI BIOPHARMACEUTICALS
CIK 0000072444
Entity typeother
Related Parties
1- filerCIK 0001459477
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 5:18 PM ET
- Size
- 8.8 KB